GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

SBFM · Sep 30, 2022

Sunshine Biopharma Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001683168-22-007290General Corporate
Operating cash generation50thOwn-history percentile · N=12
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-846.14% · OPTIONAL · VALID

Revenue growth11thOwn-history percentile · N=9
Evidence method

Yoy · gp.fundamentals.revenue

163.63% · CORE · VALID

Inventory pressure90thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

203.03% · OPTIONAL · VALID

Gross margin33thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.gross_margin

50.47% · CORE · VALID

Operating margin25thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.operating_margin

-1293.58% · CORE · VALID

R&D intensity55thOwn-history percentile · N=11
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

272.95% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History30 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Decreased
Previous
-381.75%
Current
-846.14%
Delta
-464.38%
Growth Decreased
Previous
184.27%
Current
163.63%
Delta
-20.64%
Inventory Pressure Increased
Previous
136.63%
Current
203.03%
Delta
66.40%
Margin Increased
Previous
50.31%
Current
50.47%
Delta
0.15%
Profitability Decreased
Previous
-462.92%
Current
-1293.58%
Delta
-830.67%
R And D Intensity Increased
Previous
30.57%
Current
272.95%
Delta
242.38%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.